サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1635893

経カテーテル肺動脈弁市場：技術別、原材料別、用途別、エンドユーザー別、地域別、2025-2033年

Transcatheter Pulmonary Valve Market by Technology, Raw Material, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 128 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経カテーテル肺動脈弁市場：技術別、原材料別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 128 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経カテーテル肺動脈弁市場の世界市場規模は、2024年に9,550万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1億9,170万米ドルに達し、2025年から2033年にかけて7.65%の成長率（CAGR）を示すと予測しています。さまざまな心血管疾患（CVDs）の発生率の増加、広範な研究開発（R&D）活動、高齢者人口の増加が市場を牽引する主な要因の1つです。

経カテーテル肺動脈弁は、ウシ、ブタ、ヒトの心臓組織から作られる人工弁を指します。開腹手術よりも切開回数が少なく、回復も早いため、漏れたり狭くなったりした肺動脈弁を交換して血流を改善するために広く使用されています。これらの弁は、細い柔軟な管（カテーテル）を通して太い血管に挿入され、低侵襲（MI）手術が行われます。経カテーテル的肺動脈弁置換術は、痛みや回復期間が短く、合併症のリスクを下げながら症状を改善することができます。また、血流を回復させ、胸痛、息切れ、失神、疲労などの大動脈弁狭窄症の徴候や症状を軽減するのにも役立ちます。その結果、これらの弁は、心臓の異常、肺逆流、閉鎖不全症、狭窄症、動脈瘤などに幅広く応用されています。

経カテーテル肺動脈弁市場傾向：

リウマチ性心疾患、高血圧性心疾患、脳血管疾患、炎症性心疾患など、さまざまな心血管疾患（CVD）の発生率が世界中で上昇していることが、市場の成長を促す主な要因の1つとなっています。これに伴い、高齢者人口の増加、重度の大動脈弁狭窄症や僧帽弁および三尖弁閉鎖不全症に関連する変性異常の有病率の増加が、市場成長に好影響を与えています。さらに、小児の経カテーテル的肺の治療に広く製品が採用されていることも、市場の成長に寄与しています。これは主に、肺動脈狭窄症、閉鎖不全症、ファロー四徴症、その他の関連疾患の頻度が増加しているためであり、効果的な治療オプションとして製品採用が促進されています。これとは別に、経カテーテル肺動脈弁置換術（TPVR）における人工知能（AI）の統合は、術前計画、危険因子の特定、診断および臨床的意思決定の強化を支援するため、市場成長に弾みをつけています。また、バルーン拡張技術に対する需要の高まりは、プロセスがより迅速かつ簡素化され、結果の精度と精度が高いことから、市場成長にプラスの影響を与えています。このほか、ニチノール製の自己拡張型大動脈弁システムであるヒドラ大動脈弁の発売は、弁の正確な配置を可能にし、同所配置を確実にするため、市場成長を後押ししています。その他の要因としては、革新的な心臓弁に対する需要の高まり、高血圧症例の増加、ヘルスケア産業の成長、消費者の支出能力の上昇、広範な研究開発（R&D）活動、効率的な経カテーテル肺動脈弁を開発するための様々な政府イニシアチブの実施などが挙げられ、市場の見通しは明るいと予想されます。

本レポートで扱う主な質問

  • 世界の経カテーテル肺動脈弁市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 経カテーテル肺動脈弁市場の世界市場における促進要因、抑制要因、機会は何か？
  • 主要な地域市場とは？
  • 最も魅力的な経カテーテル肺動脈弁市場はどの国か？
  • 技術別の市場内訳は？
  • 原材料別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 世界の経カテーテル肺動脈弁市場の競合構造は？
  • 経カテーテル肺動脈弁市場の世界市場における主要プレーヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の経カテーテル肺動脈弁市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • バルーン拡張型経カテーテル弁
    • 市場動向
    • 市場予測
  • 自己拡張型経カテーテル弁
    • 市場動向
    • 市場予測

第7章 市場内訳：原材料別

  • 組織工学
    • 市場動向
    • 市場予測
  • 合成
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • ファロー四徴症
    • 市場動向
    • 市場予測
  • 心臓異常
    • 市場動向
    • 市場予測
  • 肺動脈閉鎖症
    • 市場動向
    • 市場予測
  • 肺動脈狭窄
    • 市場動向
    • 市場予測
  • 肺逆流症
    • 市場動向
    • 市場予測
  • 動脈幹
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 成人
    • 市場動向
    • 市場予測
  • 小児
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第11章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Artivion Inc.
    • Boston Scientific Corporation
    • Braile Biomedica
    • Colibri Heart Valve LLC
    • Edwards Lifesciences Corporation
    • JenaValve Technology Inc.
    • Labcor Laboratorios Ltda.
    • Medtronic plc
    • Venus Medtech（Hangzhou）Inc.
図表

List of Figures

  • Figure 1: Global: Transcatheter Pulmonary Valve Market: Major Drivers and Challenges
  • Figure 2: Global: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Transcatheter Pulmonary Valve Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Transcatheter Pulmonary Valve Market: Breakup by Raw Material (in %), 2024
  • Figure 6: Global: Transcatheter Pulmonary Valve Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Transcatheter Pulmonary Valve Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Transcatheter Pulmonary Valve Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Transcatheter Pulmonary Valve (Balloon-Expanded Transcatheter Valve) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Transcatheter Pulmonary Valve (Balloon-Expanded Transcatheter Valve) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Transcatheter Pulmonary Valve (Self-Expanded Transcatheter Valve) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Transcatheter Pulmonary Valve (Self-Expanded Transcatheter Valve) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Transcatheter Pulmonary Valve (Tissue Engineered) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Transcatheter Pulmonary Valve (Tissue Engineered) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Transcatheter Pulmonary Valve (Synthetic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Transcatheter Pulmonary Valve (Synthetic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Transcatheter Pulmonary Valve (Tetralogy of Fallot) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Transcatheter Pulmonary Valve (Tetralogy of Fallot) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Transcatheter Pulmonary Valve (Cardiac Anomaly) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Transcatheter Pulmonary Valve (Cardiac Anomaly) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Transcatheter Pulmonary Valve (Pulmonary Atresia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Transcatheter Pulmonary Valve (Pulmonary Atresia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Transcatheter Pulmonary Valve (Pulmonary Stenosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Transcatheter Pulmonary Valve (Pulmonary Stenosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Transcatheter Pulmonary Valve (Pulmonary Regurgitation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Transcatheter Pulmonary Valve (Pulmonary Regurgitation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Transcatheter Pulmonary Valve (Truncus Arteriosus) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Transcatheter Pulmonary Valve (Truncus Arteriosus) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Transcatheter Pulmonary Valve (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Transcatheter Pulmonary Valve (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Transcatheter Pulmonary Valve (Adult) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Transcatheter Pulmonary Valve (Adult) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Transcatheter Pulmonary Valve (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Transcatheter Pulmonary Valve (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Transcatheter Pulmonary Valve Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Transcatheter Pulmonary Valve Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Transcatheter Pulmonary Valve Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Transcatheter Pulmonary Valve Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Transcatheter Pulmonary Valve Industry: Value Chain Analysis
  • Figure 86: Global: Transcatheter Pulmonary Valve Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcatheter Pulmonary Valve Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Raw Material (in Million USD), 2025-2033
  • Table 4: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Transcatheter Pulmonary Valve Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Transcatheter Pulmonary Valve Market: Competitive Structure
  • Table 8: Global: Transcatheter Pulmonary Valve Market: Key Players
目次
Product Code: SR112025A6954

The global transcatheter pulmonary valve market size reached USD 95.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 191.7 Million by 2033, exhibiting a growth rate (CAGR) of 7.65% during 2025-2033. The increasing incidence of various cardiovascular diseases (CVDs), extensive research and development (R&D) activities, and the rising geriatric population represent some of the key factors driving the market.

A transcatheter pulmonary valve refers to an artificial valve made from cow, pig, or human heart tissue. It is widely used to replace leaky or narrowed pulmonary valves to improve blood flow, with fewer incisions and faster recovery than open surgery. These valves are inserted through a thin, flexible tube (catheter) into a large blood vessel involving a minimally invasive (MI) procedure. Transcatheter pulmonary valve replacement involves less pain and a shorter recovery period and helps in improving symptoms while lowering the risk of medical complications. It also helps to restore blood flow and reduce the signs and symptoms of aortic valve stenosis, such as chest pain, shortness of breath, fainting, and fatigue. As a result, these valves find extensive applications in cardiac anomaly, pulmonary regurgitation, atresia, stenosis, and truncus arteriosus.

Transcatheter Pulmonary Valve Market Trends:

The rising incidences of various cardiovascular diseases (CVDs), such as rheumatic heart disorders, hypertensive heart diseases, cerebrovascular diseases, and inflammatory heart diseases across the globe, are among the key factors driving the market growth. In line with this, the rising geriatric population and increasing prevalence of degenerative abnormalities associated with severe aortic stenosis and mitral and tricuspid regurgitation are favoring the market growth. Moreover, the widespread product adoption in the treatment of pediatric transcatheter pulmonary is contributing to the market growth. This can be primarily attributed to the increasing frequency of pulmonary stenosis, atresia, tetralogy of Fallot, and other related disorders, which is facilitating the product adoption as an effective treatment option. Apart from this, the integration of artificial intelligence (AI) in the transcatheter pulmonary valve replacement (TPVR) procedure, as it assists in pre-procedural planning, identifying risk factors, and enhancing diagnosis and clinical decision-making, is providing an impetus to the market growth. Additionally, the increasing demand for balloon-expanded technology as it involves a faster and simpler process and offers high accuracy and precision of the result is positively influencing the market growth. Besides this, the launch of the hydra aortic valve, which is a self-expanding supra-annular aortic system made of nitinol that allows precise placement of the valve and ensures orthotopic deployment, is propelling the market growth. Other factors, including growing demand for innovative heart valves, an increasing number of hypertension cases, escalating growth in the healthcare industry, rising expenditure capacities of consumers, extensive research and development (R&D) activities, and the implementation of various government initiatives to develop efficient transcatheter pulmonary valves, are anticipated to create a positive outlook for the market.

Key Market Segmentation:

Technology Insights:

  • Balloon-Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve

Raw Material Insights:

  • Tissue Engineered
  • Synthetic

Application Insights:

  • Tetralogy of Fallot
  • Cardiac Anomaly
  • Pulmonary Atresia
  • Pulmonary Stenosis
  • Pulmonary Regurgitation
  • Truncus Arteriosus
  • Others

End User Insights:

  • Adult
  • Pediatric

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others);Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for transcatheter pulmonary valve. Some of the factors driving the North America transcatheter pulmonary valve market included the rising geriatric population, growing demand for innovative heart valves, and various technological advancements.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global transcatheter pulmonary valve market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Artivion Inc., Boston Scientific Corporation, Braile Biomedica, Colibri Heart Valve LLC, Edwards Lifesciences Corporation, JenaValve Technology Inc., Labcor Laboratorios Ltda., Medtronic plc, Venus Medtech (Hangzhou) Inc., etc.

Key Questions Answered in This Report:

  • How has the global transcatheter pulmonary valve market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global transcatheter pulmonary valve market?
  • What are the key regional markets?
  • Which countries represent the most attractive transcatheter pulmonary valve markets?
  • What is the breakup of the market based on technology?
  • What is the breakup of the market based on the raw material?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global transcatheter pulmonary valve market?
  • Who are the key players/companies in the global transcatheter pulmonary valve market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcatheter Pulmonary Valve Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Balloon-Expanded Transcatheter Valve
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Self-Expanded Transcatheter Valve
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Raw Material

  • 7.1 Tissue Engineered
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Tetralogy of Fallot
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Anomaly
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pulmonary Atresia
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pulmonary Stenosis
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pulmonary Regurgitation
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Truncus Arteriosus
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Adult
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pediatric
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Artivion Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Braile Biomedica
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Colibri Heart Valve LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Edwards Lifesciences Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 JenaValve Technology Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Labcor Laboratorios Ltda.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Venus Medtech (Hangzhou) Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.